Works have now commenced on the first phase of works for the extension and refurbishment of Oxford BioMedica (OXB) manufacturing facility in Cowley, Oxford. After OXB secured an Advanced Manufacturing Supply Chain Initiative (AMSCI) grant, Glanville was appointed in 2014 as the structural engineer for the expansion and reorganisation of the site.
The proposal increases the manufacturing capacity of OXB’s existing facility, together with infrastructure improvements and modernisation, but also provides additional newly constructed clean rooms to accommodate future larger-scale/commercial manufacturing processes.
